2026-01-18 - Analysis Report
**Financial Report: Abbott Laboratories (ABT)**

### Company Overview
Abbott Laboratories (ABT) is a global healthcare company that focuses on research, development, and manufacture of diverse healthcare products.

### Performance Comparison

* **Return Rate**: 
  * Cumulative return of ABT: 32.54%
  * Cumulative return of S&P 500 (VOO): 93.36%
  * Degree of divergence (on the last day of data): -60.82%
* **Alpha, Beta analysis**:
  * See the table below for the provided data.

  | Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
  |------------|------|------|-------|------|-------|
  | 2016-2018  | 32.0% | 14.5% | 29.0% | 1.1 | 125.9B |
  | 2017-2019  | 41.0% | 14.5% | 24.0% | 1.0 | 151.2B |
  | 2018-2020  | -1.0% | 16.8% | -22.0% | 0.9 | 190.6B |
  | 2019-2021  | 42.0% | 16.8% | -2.0% | 0.8 | 244.9B |
  | 2020-2022  | -20.0% | 28.8% | -18.0% | 0.8 | 191.1B |
  | 2021-2023  | -22.0% | 28.8% | -23.0% | 0.7 | 191.6B |
  | 2022-2024  | -31.0% | 24.3% | -50.0% | 0.7 | 196.9B |
  | 2023-2025  | 10.0% | 16.0% | -52.0% | 0.3 | 218.1B |

### Recent Stock Price Fluctuations

* **5-day**: $121.76
* **20-day**: $123.85
* **60-day**: $125.12
* **Current Price**: $121.76
* **Last-Market Change**: -1.43
* **Current Price vs moving averages**: The current price ($121.76) is lower than the 20-day ($123.85) and 60-day ($125.12) moving averages.

### Financial Analysis

* **Rsi, Ppo indices**: RSI = 39.06, PPO = -0.24
* **Market Risk Indicator (MRI)**: 0.80
* **Risk Level**: Medium
* **Expected Return**: -1606.10%
* **Recent relative divergence change**: -3.60 (-): worsening

### Recent News & Significant Events

1. [2026-01-17] Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock for Income Investors - Chartmill (news.google.com)
2. [2026-01-17] Is Abbott Laboratories (ABT) Price Weakness Creating A Potential Opportunity Now? - Yahoo Finance (news.google.com)
3. [2026-01-16] Fund Update: New $84.6M $ABT stock position opened by Compagnie Lombard Odier SCmA - Quiver Quantitative (news.google.com)
4. [2026-01-16] Absolute Software Co. (ABT.TO) (TSE:ABT) Stock Crosses Above Two Hundred Day Moving Average - Here's Why - MarketBeat (news.google.com)
5. [2026-01-05] How to listen as Abbott breaks down its latest quarterly results Jan. 22 - Stock Titan (news.google.com)
6. [2025-12-24] Abbott Laboratories Shrugs Off Tariffs & China Headwinds With 7% Dividend Raise (NYSE:ABT) - Seeking Alpha (news.google.com)

### Analyst Opinions

```markdown
 Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.71 (~Buy)
- Opinions: 25
- Target Price (avg/high/low): 144.75 / 169.00 / 122.00
```

### Recent Earnings Analysis

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-29 | $0.94 | $11.37 B$ |
| 2025-07-30 | $1.02 | $11.14 B$ |
| 2025-04-30 | $0.76 | $10.36 B$ |
| 2024-10-31 | $0.94 | $10.63 B$ |
| 2025-10-29 | $0.94 | $10.63 B$ |

### Financial Information

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $11.37B | 55.36% |
| 2025-06-30 | $11.14B | 56.44% |
| 2025-03-31 | $10.36B | 56.86% |
| 2024-12-31 | $10.97B | 54.97% |
| 2024-09-30 | $10.63B | 55.83% |

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $50.95B | 3.23% |
| 2025-06-30 | $50.56B | 3.52% |
| 2025-03-31 | $48.81B | 2.71% |
| 2024-12-31 | $47.66B | 19.36% |
| 2024-09-30 | $39.80B | 4.14% |

### Comprehensive Analysis (Summary of previous items)

* Cumulative return of ABT: 32.54%
* Degree of divergence from S&P 500: -60.82%
* Recent financial news: ABT has stood out as a dependable dividend stock, shrugs off tariffs and China headwinds, and price weakness creating a potential opportunity.
* Market Risk Indicator (MRI): 0.80
* RSI and PPO indices: 39.06 and -0.24
* Expected Return: -1606.10%

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.